DHR Danaher Corporation

DHR Danaher Corporation

Healthcare · Diagnostics & Research

Desk view

Watchingmedium conviction · entry after a pullback to the $210.39 volume shelf, holds and turns back above it with RSI in the 55-65 reset band and relative volume at least 1.0x — not entered
Basis Open desk call ·Logged decision
Perspectives Biotech Capital Cycle
Updated

Market read

Scan convergence 1 scan as of 2026-10-16 1 bull converging

POC $224.04 · VWAP $203.51 · +13.3% vs 12m avg buyer

uptrend vol: normalchurn: quiet as of

Insiders selling 0 buy / 1 sell · Form 4, 90d $12.7M sold last open-market sell Blair Rainer

Coverage

3 watchlists

Watchlists @biotech-capital-cycle@biotech-scan@trace-glp1-manufacturing

DHR Price Structure

Loading chart…

Loading timeframes…

Peers

Every watchlist DHR belongs to, members best 30-day change first — DHR highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.

@trace-glp1-manufacturing
View watchlist →
STE+10.6% 0.0%1d +4.3%7d BDX+9.0% -0.8%1d +3.7%7d WAT+7.9% -0.4%1d +3.8%7d WST+4.3% -0.5%1d +2.1%7d DHR+4.0% +0.3%1d +0.6%7d TMO+1.3% -0.4%1d -2.3%7d STVN-10.1% -0.1%1d +3.1%7d
@biotech-capital-cycle
View watchlist →
NAUT+239.7% +24.6%1d +57.3%7d QSI+84.5% +21.7%1d +25.0%7d PACB+49.6% +2.4%1d +22.0%7d CRL+24.5% +1.7%1d +15.1%7d FTRE+21.1% -1.2%1d +5.1%7d CERT+19.6% +2.4%1d +10.3%7d AVTR+17.1% +0.8%1d +5.3%7d DNA+16.4% +2.9%1d -2.7%7d ICLR+13.0% -0.1%1d +8.9%7d MTD+11.9% -0.8%1d +3.0%7d RVTY+11.7% +0.9%1d +4.0%7d SEER+9.4% 0.0%1d -3.0%7d MEDP+8.4% +2.3%1d +8.2%7d AGIO+8.2% -0.5%1d +18.1%7d WAT+7.9% -0.4%1d +3.8%7d ILMN+5.5% 0.0%1d +2.6%7d A+4.7% -0.5%1d +0.1%7d IQV+4.3% +0.4%1d +4.7%7d DHR+4.0% +0.3%1d +0.6%7d TMO+1.3% -0.4%1d -2.3%7d RXRX0.0% +3.4%1d +6.6%7d BRKR-3.5% +0.5%1d +5.1%7d XBI-3.6% -1.4%1d +3.6%7d ABCL-4.0% +4.0%1d +0.2%7d RGEN-4.1% -1.0%1d +0.9%7d ALMR-4.5% +3.3%1d +21.4%7d TXG-5.4% +2.6%1d +2.4%7d ABSI-5.8% -2.0%1d +11.3%7d CDXS-7.3% -2.3%1d +3.2%7d QTRX-9.5% +0.7%1d -0.3%7d TEM-11.7% +6.0%1d +4.5%7d TWST-11.7% +3.3%1d +5.4%7d LAB-18.4% -4.7%1d -3.7%7d SDGR-18.6% +5.3%1d +5.3%7d GENB-24.9% -3.0%1d +2.6%7d VKTX-41.4% -5.5%1d -3.1%7d
@biotech-scan
View watchlist →
GRAL+22.1% +4.3%1d +12.5%7d DNA+16.4% +2.9%1d -2.7%7d ISRG+13.6% +1.9%1d +6.0%7d LLY+10.6% -2.5%1d +1.3%7d BIIB+10.2% -1.2%1d +7.8%7d MRNA+9.9% -1.3%1d -8.2%7d AMGN+8.2% -1.8%1d +1.6%7d ABBV+7.8% +0.2%1d +0.1%7d MDT+6.8% -1.2%1d +0.7%7d ILMN+5.5% 0.0%1d +2.6%7d RARE+5.2% -1.9%1d +7.6%7d A+4.7% -0.5%1d +0.1%7d LEGN+4.4% +2.0%1d +4.3%7d IQV+4.3% +0.4%1d +4.7%7d DHR+4.0% +0.3%1d +0.6%7d GILD+3.1% -0.7%1d -0.1%7d NVO+2.3% -1.0%1d +0.6%7d VRTX+1.5% -2.1%1d +4.8%7d TMO+1.3% -0.4%1d -2.3%7d IBB+0.6% -0.9%1d +2.9%7d REGN+0.4% -1.7%1d +1.8%7d RXRX0.0% +3.4%1d +6.6%7d PTGX-0.2% -0.8%1d +7.5%7d COGT-0.6% -0.3%1d +5.7%7d IBBQ-0.7% -1.1%1d +2.4%7d BEAM-1.3% -2.1%1d +2.5%7d IONS-2.3% -2.2%1d 0.0%7d XBI-3.6% -1.4%1d +3.6%7d KYMR-4.1% -0.1%1d +5.7%7d DFTX-5.3% -0.9%1d +11.1%7d SRPT-6.4% -2.5%1d +3.7%7d INCY-7.2% -1.0%1d +2.3%7d NTLA-9.1% +0.5%1d -1.8%7d ALNY-9.1% -1.4%1d -3.4%7d BMRNE-10.1% -1.2%1d +2.3%7d BNTX-10.5% -1.7%1d +0.5%7d EDIT-10.8% -3.6%1d +2.1%7d DXCM-11.2% -0.5%1d -9.4%7d CRSP-11.4% -1.2%1d +0.3%7d IMVT-17.8% -2.4%1d +6.3%7d NKTR-35.5% -3.7%1d +4.0%7d

Decision history

1 scored call · newest first · projection

How to read this: Positive 30-day excess supports an enter call. For pass, avoid, sell, or exit calls, a positive number means the name kept rising after the call.

May 11 sell n/a Stop loss +12.2% complete

Desk commentary

Authored analysis and challenge notes tied to DHR.

1

Next earnings DHR reports in 96 days Jan 27 '27

Last report Oct 21

Reported EPS $2.11 versus analyst consensus of $1.92 (+10.0%).

full note →

Against street estimates

How DHR's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. A consensus out of line with the name's earlier estimates (opposite sign to all of them and over 3x their size) is not graded. EPS only.

8 most recent of 10 quarters · newest report Oct 21 · projection Oct 23

Result
Oct 21 1.922.11+10.0%Beat
Jul 21 1.841.94 GAAP ≠ +5.3%Beat
Apr 21 1.942.06 GAAP ≠ +6.5%Beat
Jan 28 2.192.23+2.0%In line
Oct 21 '25 1.721.89 GAAP ≠ +9.8%Beat
Jul 22 '25 1.641.80 GAAP ≠ +9.5%Beat
Apr 22 '25 1.641.88 GAAP ≠ +14.4%Beat
Jan 29 '25 2.162.14-1.1%In line

Recent news

Headlines about DHR from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.

pulled today · Oct 23

“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.

DHR research tape

64 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.

brief The Prints — 2026-10-21 → 2026-10-22 brief Patch Day: security software closes 11 for 11 as an AI-found web flaw takes government sites... earnings DHR earnings — 2026-10-21 earnings DHR earnings — 2026-10-20 scan Biotech Scan — October 16, 2026
Types
Oct 22 The Prints The Prints — 2026-10-21 → 2026-10-22
METATSLALRCXTXNTMOIBMABTDHR
Oct 21 Market Brief Patch Day: security software closes 11 for 11 as an AI-found web flaw takes government sites offline
AVEXASSTZCSHABSILADNTSKMEDPHSAI +4 more
Oct 21 Catalyst DHR earnings
DHR
Oct 20 Catalyst DHR earnings
DHR
Oct 16 Scan Biotech Scan
IMVTBMRNENKTRINCYNVOCOGTIONSREGN +4 more
Oct 9 Scan Biotech Scan
IMVTBMRNENKTRINCYNVOCOGTIONSREGN +4 more
Oct 2 Scan Biotech Scan
NKTRBMRNENVOIMVTIONSINCYALNYREGN +4 more
Sep 25 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Sep 23 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Sep 18 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Sep 11 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Sep 10 Market Signal Two Watches Retired on A Macro Day
DHRVRTMETALMTVICRVKTX
Sep 7 Market Brief Memory Leads, Software Splits
AMGNARKWAVALBANB.SWBDXBMYLULUPATH +4 more
Sep 6 Market Brief Micron Leads the Tuesday Entry Map
AMGNARKWAVALBANB.SWBDXBMYLULUPATH +4 more
Sep 5 Market Brief A War Priced as Rates
AMGNAMTARKWAUBDXBMYLULUPATH +4 more
Sep 4 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Sep 2 Market Brief Three Beats, Three Selloffs, and a Hike Nobody Hedged
AMBAANFAPLEATEYYATIAVTDELLCRDO +4 more
Sep 1 Market Brief Neoclouds Break as One, Gold Breaks With Them
ACLSAIQAMLXARWATRCAUNGLNMM +4 more
Sep 1 Market Signal Gate Recomputes Gold Breaks and Three Convergence Raises
GLDUUPMSFTSKHYDHRBUFR
Aug 28 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Aug 27 Market Brief A Risk-On Turn, Confirmed Three Ways
ABCLANETAPHARKKBESIYBHPNVDACRM +4 more
Aug 27 Article Congress Trade Tracker — Who Actually Beats the Index
NVDAGOOGLAMZNAAPLAVGOINTCVSTBE +4 more
Aug 26 Market Brief Concrete Bids, Compute Bleeds
ABBNYADA-USDAEVAAIPAKAMAPDCVIKSPI +4 more
Aug 25 Market Brief Biotech Goes Blue-Chip, Credit Slips Its Line
AGXAMRARKFBITXBKRBLMNPDDXPEV +4 more
Aug 25 Market Signal Credit Tell Slips Under Its Own Line — Divergence Signal
HYGTLTDHRNTLANBISSTXKRE
Aug 22 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Aug 14 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Aug 8 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Jul 31 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Jul 28 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Jul 25 Article Where Congress's traders actually agree — and where they don't
NVDAAVGOUBERMASPGIDHR
Jul 25 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Jul 21 Catalyst DHR earnings
DHR
Jul 17 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Jul 11 Scan Biotech Scan
ABBVXBIIBBIBBQLABUMRNABIIBLLY +4 more
Jul 7 Scan Biotech Scan
ABBVXBIIBBIBBQLABUMRNABIIBLLY +4 more
Jun 26 Scan Biotech Scan
ABBVXBIIBBIBBQLABUMRNABIIBLLY +4 more
Jun 25 Article Where the Entries Are
GOOGLAMZNAAPLNVDAAVGOCRWDASMLALAB +4 more
Jun 16 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
May 29 Scan Biotech Scan
AABBVALNYAMGNBEAMBIIBBMRNEBNTX +4 more
May 21 Desk Move DHR — mccaul-trades buy
DHR
May 13 Desk Move DHR — mccaul-trades buy
DHR
May 3 Desk Move DHR — mccaul-trades buy
DHR
Apr 28 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBMRNEBNTXCOGT +4 more
Apr 27 Reference Claude-Trader Playbook
ABBVABTADBEASANAVGOCEGCLXCOP +4 more
Apr 27 Reference Claude-Momentum Playbook
ABBVAMZNARMASANAVGOCRMCRSPCRWD +4 more
Apr 26 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBMRNEBNTXCOGT +4 more
Mar 31 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBMRNEBNTXCRSP +4 more
Mar 26 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBMRNEBNTXCRSP +4 more
Mar 24 Scan Biotech Scan
ABBVALNYAMGNBIIBBMRNEBNTXCRSPDHR +4 more
Mar 20 Article Market Status Report
ABBVADBEAMKREAMZNARKKASAVGOCEG +4 more
Mar 20 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBMRNEBNTXCRSP +4 more
Mar 13 Article Market Status Report
AAPLADBEAMDAMKREAMZNARKKASAVGO +4 more
Mar 13 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBMRNEBNTXCRSP +4 more
Mar 13 Article Daily Actions
AAPLADBEAMZNARMASASMLBABNTX +4 more
Mar 12 Article Market Status Report
ADBEAMZNARKKAVGOCEGCLXCMGCRM +4 more
Mar 12 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBMRNEBNTXCRSP +4 more
Mar 12 Update Biotech
ALNYBEAMBIIBBNTXCRSPDHRGILDLEGN +4 more
Mar 12 Article Daily Actions
ALERTAMZNARMASASANASMLBNTXBTC +4 more
Mar 11 Article Market Status Report
ADBEAFRMAMZNARKKASASANAVGOBNTX +4 more
Mar 11 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBLUEBMRNEBNTX +4 more
Mar 11 Article Daily Actions
AMZNARMASASANASMLBNTXBTCCEG +4 more
Mar 10 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBLUEBMRNEBNTX +4 more
Feb 2 Scan Biotech Universe
ABBVALNYAMGNBEAMBIIBBMRNEBNTXDHR +4 more